CAMG Solamere Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,258
Closed -$223K 86
2020
Q4
$223K Buy
+3,258
New +$212K 0.19% 90
2019
Q2
Sell
-43,811
Closed -$2.36M 99
2019
Q1
$2.36M Buy
43,811
+8,954
+26% +$553K 1.17% 39
2018
Q4
$2.29M Buy
34,857
+32,259
+1,242% +$2.41M 1.27% 36
2018
Q3
$204K Sell
2,598
-2,290
-47% -$164K 0.1% 111
2018
Q2
$314K Sell
4,888
-5,577
-53% -$368K 0.15% 102
2018
Q1
$647K Sell
10,465
-654
-6% -$46.9K 0.29% 87
2017
Q4
$807K Sell
11,119
-201
-2% -$14.6K 0.36% 77
2017
Q3
$921K Buy
11,320
+363
+3% +$28.7K 0.46% 71
2017
Q2
$879K Buy
10,957
+569
+5% +$44.9K 0.5% 69
2017
Q1
$816K Sell
10,388
-176
-2% -$14.1K 0.48% 73
2016
Q4
$835K Buy
+10,564
New +$855K 0.59% 60

Other funds holding CVS

CAMG Solamere Management's CVS Position: Q1 2021 in Review

CAMG Solamere Management sold out of CVS Health (CVS) in Q1 2021, closing a stake of 3,258 shares — an estimated $223K sold.

CAMG Solamere Management first reported a position in CVS in Q4 2016 and held it in 11 quarters. The position peaked at $2.36M in Q1 2019. 2,033 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • CAMG Solamere Management reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
  • CAMG Solamere Management sold 3,258 CVS Health shares in Q1 2021, an estimated $223K.
  • CAMG Solamere Management first reported a position in CVS Health in Q4 2016 and held it in 11 quarters.
  • CAMG Solamere Management's CVS Health position peaked at $2.36M in Q1 2019.
  • 2,033 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on CAMG Solamere Management's 13F filing for Q1 2021, filed 17 May 2021.